Jamie Evans, M.D.
NPI 1508800707 · Family Medicine Physician · Mc Gehee, AR
Provider details
- NPI number
- 1508800707
- Entity type
- Individual
- Primary specialty
- Family Medicine PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- Yes
- License
- 23396 (OK)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
341 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Complete Blood Cell Count (red Cells, White Blood Cell, Platelets), Automated Test and Automated Differential White Blood Cell Count85025 | 93 | $8 |
| Hemoglobin A1c Level83036 | 85 | $10 |
| Injection of Drug Or Substance Under Skin Or Into Muscle96372 | 69 | $13 |
| Insertion of Needle Into Vein for Collection of Blood Sample36415 | 35 | $4 |
| Advance Care Planning, First 30 Minutes99497 | 30 | $75 |
| Detection Test By Immunoassay Technique for Severe Acute Respiratory Syndrome Coronavirus and Influenza87428 | 29 | $69 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 128 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Atorvastatin Calcium | 321 | 85 |
| Amlodipine Besylate | 288 | 68 |
| Losartan Potassium | 253 | 59 |
| Gabapentin | 221 | 47 |
| Omeprazole | 220 | 52 |
| Empagliflozinbrand: Jardiance | 213 | 42 |
| Pantoprazole Sodium |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$123 across 6 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-06-16
- Last updated
- 2026-03-02
- Certified
- 2026-03-02
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.